Table 2 |
||||||
|
Observational Studies of Stearic Acid and Cardiovascular Outcomes |
||||||
|
Author |
Year |
Study design |
N, Population |
Stearic acid assessment method |
CHD/MI Outcomes |
Other |
|
|
||||||
|
Kromhout [141] |
1995 |
Ecologic |
12,763 men, 16 cohorts of 7CS |
Dietary intake |
↑ CHD mortality |
|
|
Simon [68, 69] |
1995 |
Prospective |
96 cases, 96 controls, USA-MRFIT |
Serum levels |
↑ CHD incidence |
Null-stroke incidence |
|
Watts [67] |
1996 |
Prospective |
50 men, Australia |
Dietary intake |
↑ CAD progression |
|
|
Hojo [61] |
1998 |
Case-control |
71 cases, 60 controls, Japan |
Serum levels |
Null-stenosis |
|
|
Hu [65] |
1999 |
Prospective |
80,082 women, USA-nurses |
Dietary intake |
↑ CHD incidence |
|
|
Yli-Jama [62] |
2002 |
Case-control |
103 cases, 104 controls, Norway |
Serum levels |
↓ MI incidence |
|
|
Kabagambe [63] |
2003 |
Case-control |
485 cases, 508 controls, Costa Rica |
Dietary intake |
↑ MI incidence |
|
|
Wang [66] |
2003 |
Prospective |
3591 whites, USA |
Serum levels |
↑ CHD mortality |
|
|
|
||||||
|
Abbreviations: 7CS, 7 Countries Study; MRFIT, Multiple Risk Factor Intervention Trial; * High stearic acid level among men from geographic areas of high IHD mortality |
||||||
|
Ding et al. Nutrition & Metabolism 2006 3:2 doi:10.1186/1743-7075-3-2 |
||||||